What is the market valuation of arthroscopy?

In 2027 the market for arthroscopy is worth approximately USD 6.98 billion.

How is the arthroscopy industry size expected to evolve during the forecast period?

Arthroscopy Market size was worth USD 6.8 billion in 2026 and is expected to grow at a 3.23% CAGR between 2027 and 2036, reaching USD 9.34 billion by 2036.

How are demographic and disease trends influencing demand in the arthroscopy market?

Rising osteoarthritis prevalence and aging populations are increasing demand for minimally invasive joint preservation procedures, driving greater utilization of arthroscopic instruments and visualization systems that support faster recovery and reduced procedural trauma.

Why are hospitals and surgical centers investing in advanced arthroscopy visualization and fluid management technologies?

Enhanced 3D visualization and fluid management improve procedural precision, operating efficiency, and workflow consistency, encouraging providers to upgrade capital equipment to support higher throughput and better outcomes in complex joint interventions.

Why does knee arthroscopy lead the arthroscopy market?

Knee arthroscopy held a 44.2% market share in 2026, driven by high procedure volumes for knee injuries and degenerative conditions, along with continued reliance on minimally invasive techniques that support precision and recovery.

Why are visualization systems the fastest-growing product segment in the arthroscopy market?

Visualization Systems are growing fastest because providers increasingly prioritize image clarity, workflow efficiency, and improved intraoperative visibility, while technology upgrade cycles continue to drive modernization of arthroscopy suites.

Why does North America lead the arthroscopy market?

North America leads due to a mature sports medicine ecosystem, high procedure volumes, widespread minimally invasive adoption, and strong hospital and ambulatory surgical infrastructure with trained orthopedic specialists.

How is Asia Pacific driving the fastest growth in the arthroscopy market?

Asia Pacific grows at 4.45% CAGR, driven by expanding orthopedic access, improving surgical infrastructure, rising sports injuries, and increasing adoption across urban healthcare centers.

Which companies dominate the arthroscopy landscape?

Major companies in the arthroscopy market include Arthrex, Inc. (United States), Smith & Nephew plc (United Kingdom), Stryker Corporation (United States), Zimmer Biomet Holdings, Inc. (United States), Johnson & Johnson (DePuy Synthes) (United States), CONMED Corporation (United States), Karl Storz SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), Medtronic plc (Ireland), Olympus Corporation (Japan).